Skip to content

Sevoflurane and propofol combined with rectus sheath nerve block in the operation of open rectal cancer

Sevoflurane and propofol combined with rectus sheath nerve block in the operation of open rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038845
Enrollment
Unknown
Registered
2020-10-06
Start date
2020-10-19
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sevoflurane and propofol combined with rectus sheath nerve block in the operation of open rectal cancer

Interventions

Sevoflurane combined with rectus sheath:Anesthesia was maintained by sevoflurane + remifentanil + dexmedetomidine + muscle relaxant cis-type atracurium pump injection
Propofol combined with rectus sheath:Anesthesia was maintained by propofol + remifentanil + dexmedetomidine + muscle relaxant cis atracurium pump injection

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent; 2. Aged 40-75 years; 3. ASA grade I~III; 4. to choose a period of open surgery for rectal cancer patients.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to regional blocking techniques (allergic to local anesthetics, peripheral infection at the puncture site and coagulation disorders); 2. A history of pain reliever dependence; 3. Patients with dementia or severe cognitive impairment; 4. Any cerebrovascular accident occurred within 3 months, such as stroke, transient ischemic attack (TIA), etc.; 5. Any communication difficulty.

Design outcomes

Primary

MeasureTime frame
Intraoperative opioid demand;

Secondary

MeasureTime frame
The dosage of anesthetic drugs, vasoactive drugs and the amount of liquid in and out during the operation;Intraoperative hemodynamic fluctuation;The incidence, duration and occurrence time of postoperative delirium;The patient's recovery time, extubation time and in and out PACU time;Postoperative analgesic drug dosage and resting and exercise pain score at each follow-up time point (NRS score, 0-10);Number of analgesic pump compressions and effective number of analgesic pump compressions at 24h and 48h postoperatively;Postoperative major organ complications and length of stay;30-day postoperative mortality (telephone follow-up);

Countries

China

Contacts

Public ContactXu Guanghong

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

xuguanghong2004@163.com+86 13856949535

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026